FABP2 and cystic fibrosis: Sixty-eight CF patients were eligible for inclusion (Table 1): serum I-FABP levels were analysed in 56 CF patients (I-FABP group, S1 File) whereas faecal calprotectin levels were available in 43 CF patients (calprotectin group, S2 File).